PHARMACOGENETIC HLA-B☆58:01 TESTING TO PREVENT ALLOPURINOL-INDUCED SJS']JS/TEN IN VIETNAMESE POPULATION: A COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Duong, K. [1 ]
Nguyen, D., V [2 ]
Chaiyakunapruk, N. [1 ]
Nelson, R. E. [3 ]
Malone, D. C. [1 ]
机构：
[1] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT USA
[2] Vinmec Healthcare Syst, Dept Internal Med, Resp Allergy & Clin Immunol Unit, Hanoi, Vietnam
[3] Univ Utah, Sch Med, Div Epidemiol, Salt Lake City, UT USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE94
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 40 条
  • [1] Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS']JS/TEN in Thai Population
    Saokaew, Surasak
    Tassaneeyakul, Wichittra
    Maenthaisong, Ratree
    Chaiyakunapruk, Nathorn
    [J]. PLOS ONE, 2014, 9 (04):
  • [2] Clinical Utility ofHLA-B*58:01Genotyping to Prevent Allopurinol-Induced SJS']JS/TEN
    Lavu, Alekhya
    Thiriveedi, Sneha
    Thomas, Levin
    Khera, Kanav
    Saravu, Kavitha
    Rao, Mahadev
    [J]. HOSPITAL PHARMACY, 2021, 56 (06) : 660 - 663
  • [3] Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population
    Chong, Huey Yi
    Lim, Yi Heng
    Prawjaeng, Juthamas
    Tassaneeyakul, Wichittra
    Mohamed, Zahurin
    Chaiyakunapruk, Nathorn
    [J]. PHARMACOGENETICS AND GENOMICS, 2018, 28 (02): : 56 - 67
  • [4] Allopurinol-induced DRESS in a Han Chinese with HLA-B*58:01 allele
    Kooybaran, Neda Rahbar
    Isik, Sara
    Forkel, Susann
    Schoen, Michael P.
    Buhl, Timo
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 5 - 5
  • [5] HLA-B*58:01 Genotyping to Prevent Cases of DRESS and SJS']JS/TEN in East Asians Treated with Allopurinol-A Canadian Missed Opportunity
    Ponzo, Marisa Grace
    Miliszewski, Monica
    Kirchhof, Mark G.
    Keown, Paul A.
    Dutz, Jan P.
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (06) : 595 - 601
  • [6] A CASE SERIES OF HLA-B*58:01 SPECIFIC ALLOPURINOL-INDUCED DRESS/DIHS
    Diaz, A.
    Sani, S.
    Mawhirt, S.
    Banta, E.
    Fonacier, L.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S97 - S98
  • [7] COST-EFFECTIVENESS ANALYSIS OF HLA-B*5801 GENETIC TESTING PRIOR TO INITIATION OF ALLOPURINOL THERAPY TO PREVENT ALLOPURINOL-INDUCED STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN MALAYSIAN POPULATION
    Chong, H. Y.
    Lim, Y. H.
    Prawjaeng, J.
    Chaiyakunapruk, N.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A6 - A6
  • [8] HLA-B*58:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample population
    Niihara, Hiroyuki
    Kaneko, Sakae
    Ito, Takahumi
    Sugamori, Takashi
    Takahashi, Nobuyuki
    Kohno, Kunie
    Morita, Eishin
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2013, 71 (02) : 150 - 152
  • [9] Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout
    Plumpton, Catrin O.
    Alfirevic, Ana
    Pirmohamed, Munir
    Hughes, Dyfrig A.
    [J]. RHEUMATOLOGY, 2017, 56 (10) : 1729 - 1739
  • [10] Detection of HLA-B*58: 01 with TaqMan assay and its association with allopurinol-induced sCADR
    Zhang, Xinju
    Ma, Huili
    Hu, Chunying
    Yu, Bo
    Ma, Weizhe
    Wu, Zhiyuan
    Luo, Xiaoqun
    Zou, Hejian
    Guan, Ming
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (03) : 383 - 390
1234